Design of novel focal adhesion kinase inhibitors using 3D-QSAR and molecular docking

被引:0
作者
Xia Lu
Lingzhou Zhao
Tian Xue
Huabei Zhang
机构
[1] Beijing Normal University,Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry
[2] Beijing Aerospace Hospital,Medical Image Center
来源
Medicinal Chemistry Research | 2014年 / 23卷
关键词
Focal adhesion kinase; Inhibitors; Docking; 3D-QSAR; CoMFA; CoMSIA;
D O I
暂无
中图分类号
学科分类号
摘要
Focal adhesion kinase (FAK) plays a primary role in regulating the activity of many signaling molecules. Increased FAK expression has been implicated in a series of cellular processes, including cell migration and survival. Inhibiting the activity of FAK for cancer therapy is currently under investigation. Hence, FAK and its inhibitors have been the subject of intensive research. To understand the structural factors affecting inhibitory potency, molecular docking and 3D-QSAR modeling were studied in this project. CoMFA and CoMSIA methods were used for deriving 3D-QSAR models, which were trained with 78 compounds and then were evaluated for predictive ability with additional 19 compounds. Two substructure-based 3D-QSAR models, including CoMFA model (r2 = 0.930; q2 = 0.629) and CoMSIA model (r2 = 0.952; q2 = 0.586), had a good quality to predict the biological activities of new compounds. Meanwhile, using the flexible docking strategy, two docking-based 3D-QSAR models (CoMFA with r2 = 0.914; q2 = 0.594; CoMSIA with r2 = 0.914; q2 = 0.524) were also constructed. The structure–activity relationship has been illustrated clearly by the contour maps gained from the 3D-QSAR models in combination with the docked binding structures. All the results indicated that it might be useful in the rational design of novel FAK inhibitors.
引用
收藏
页码:1976 / 1997
页数:21
相关论文
共 390 条
  • [41] Umemura I(2010)PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments Cancer Biol Ther 9 764-1000
  • [42] Matsuura N(2009)Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors Eur J Med Chem 44 990-4706
  • [43] Ohmori O(2005)Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation Cancer Res 65 4698-790
  • [44] Honda T(2010)Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models Cancer Biol Ther 9 778-4639
  • [45] Gray N(2008)Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo Clin Cancer Res 14 4631-698
  • [46] He Y(2005)Specific induction of pp125 focal adhesion kinase in human breast cancer Br J Cancer 93 694-784
  • [47] Choi HS(1984)A new force field for molecular mechanical simulation of nucleic acids and proteins J Am Chem Soc 106 765-421
  • [48] Wang Z(1994)Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain Mol Biol Cell 5 413-655
  • [49] Richmond W(2011)Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer Breast Cancer Res Treat 28 647-49
  • [50] He X(2009)Signal transduction by focal adhesion kinase in cancer Cancer Metastasis Rev 28 35-undefined